Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.
Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.
复制标题
抑制线粒体翻译是人类急性髓样白血病的治疗策略。
DOI:
10.1016/j.ccr.2011.10.015
复制
发表时间:
2011-11-15
期刊:
影响因子:
50.3
通讯作者:
Schimmer AD
中科院分区:
文献类型:
--
作者:
Skrtić M;Sriskanthadevan S;Jhas B;Gebbia M;Wang X;Wang Z;Hurren R;Jitkova Y;Gronda M;Maclean N;Lai CK;Eberhard Y;Bartoszko J;Spagnuolo P;Rutledge AC;Datti A;Ketela T;Moffat J;Robinson BH;Cameron JH;Wrana J;Eaves CJ;Minden MD;Wang JC;Dick JE;Humphries K;Nislow C;Giaever G;Schimmer AD
To identify FDA-approved agents targeting leukemic cells, we performed a chemical screen on two human leukemic cell lines and identified the antimicrobial tigecycline. A genome-wide screen in yeast identified mitochondrial translation inhibition as the mechanism of tigecycline-mediated lethality. Tigecycline selectively killed leukemia stem and progenitor cells compared to their normal counterparts and also showed anti-leukemic activity in mouse models of human leukemia. ShRNA-mediated knockdown of EF-Tu mitochondrial translation factor in leukemic cells reproduced the anti-leukemia activity of tigecycline. These effects were derivative of mitochondrial biogenesis which, together with an increased basal oxygen consumption, proved to be enhanced in AML versus normal hematopoietic cells and were also important for their difference in tigecycline sensitivity.
登录
查看更多内容
影响因子:
4.8
作者:
Li, NY;Ragheb, K;Robinson, JP
通讯作者:
Robinson, JP
影响因子:
4.8
作者:
Koc, EC;Spremulli, LL
通讯作者:
Spremulli, LL
影响因子:
64.5
作者:
Gupta PB;Onder TT;Jiang G;Tao K;Kuperwasser C;Weinberg RA;Lander ES
通讯作者:
Lander ES
影响因子:
4.9
作者:
McKee, EE;Ferguson, M;Marks, TA
通讯作者:
Marks, TA
DOI:
10.1073/pnas.0700690104
发表时间:
2007-04-10
影响因子:
11.1
作者:
Funes, Juan M.;Quintero, Marisol;Boshoff, Chris
通讯作者:
Boshoff, Chris